Login to Your Account

TIL kingdom comes? Data with Oncosec's approach lifting hope in melanoma

By Randy Osborne
Staff Writer

Wednesday, April 20, 2016

Positive data with Oncosec Medical Inc.'s Immunopulse interleukin-12 electroporation therapy against melanoma "set pulses racing," in the words of H.C. Wainwright analyst Mark Breidenbach.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription